BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33278490)

  • 1. Mice with an RGS-insensitive Gα
    Omouessi ST; Leipprandt JR; Akoume MY; Charbeneau R; Wade S; Neubig RR
    Mol Cell Endocrinol; 2021 Feb; 521():111098. PubMed ID: 33278490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender-dependent role of endogenous somatostatin in regulating growth hormone-axis function in mice.
    Luque RM; Kineman RD
    Endocrinology; 2007 Dec; 148(12):5998-6006. PubMed ID: 17761762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GH in the dwarf dopaminergic D2 receptor knockout mouse: somatotrope population, GH release, and responsiveness to GH-releasing factors and somatostatin.
    García-Tornadú I; Rubinstein M; Gaylinn BD; Hill D; Arany E; Low MJ; Díaz-Torga G; Becu-Villalobos D
    J Endocrinol; 2006 Sep; 190(3):611-9. PubMed ID: 17003262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of GHRH and GHRP-2 treatment in vitro on GH secretion and levels of GH, pituitary transcription factor-1, GHRH-receptor, GH-secretagogue-receptor and somatostatin receptor mRNAs in ovine pituitary cells.
    Yan M; Hernandez M; Xu R; Chen C
    Eur J Endocrinol; 2004 Feb; 150(2):235-42. PubMed ID: 14763922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels.
    Kineman RD; Kamegai J; Frohman LA
    Endocrinology; 1999 Aug; 140(8):3581-6. PubMed ID: 10433214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in mRNA concentrations of pituitary receptors for growth hormone-releasing hormone and growth hormone secretagogues after neonatal monosodium glutamate treatment.
    Kovacs M; Kineman RD; Schally AV; Flerko B; Frohman LA
    J Neuroendocrinol; 2000 Apr; 12(4):335-41. PubMed ID: 10718930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pituitary alterations involved in the decline of growth hormone gene expression in the pituitary of aging rats.
    Frutos MG; Cacicedo L; Méndez CF; Vicent D; González M; Sánchez-Franco F
    J Gerontol A Biol Sci Med Sci; 2007 Jun; 62(6):585-97. PubMed ID: 17595414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homologous and heterologous regulation of pituitary receptors for ghrelin and growth hormone-releasing hormone.
    Luque RM; Kineman RD; Park S; Peng XD; Gracia-Navarro F; Castaño JP; Malagon MM
    Endocrinology; 2004 Jul; 145(7):3182-9. PubMed ID: 15044357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression analysis of hypothalamic and pituitary components of the growth hormone axis in fasted and streptozotocin-treated neuropeptide Y (NPY)-intact (NPY+/+) and NPY-knockout (NPY-/-) mice.
    Park S; Peng XD; Frohman LA; Kineman RD
    Neuroendocrinology; 2005; 81(6):360-71. PubMed ID: 16244497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary mRNA expression of the growth hormone axis in the 1-year-old intrauterine growth restricted rat.
    Prins T; Fodor M; Delemarre-van de Waal HA
    J Neuroendocrinol; 2006 Aug; 18(8):611-20. PubMed ID: 16867182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of leptin replacement on hypothalamic-pituitary growth hormone axis function and circulating ghrelin levels in ob/ob mice.
    Luque RM; Huang ZH; Shah B; Mazzone T; Kineman RD
    Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E891-9. PubMed ID: 17122091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examination of the direct effects of metabolic factors on somatotrope function in a non-human primate model, Papio anubis.
    Luque RM; Gahete MD; Valentine RJ; Kineman RD
    J Mol Endocrinol; 2006 Aug; 37(1):25-38. PubMed ID: 16901921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback.
    Peng XD; Park S; Gadelha MR; Coschigano KT; Kopchick JJ; Frohman LA; Kineman RD
    Endocrinology; 2001 Mar; 142(3):1117-23. PubMed ID: 11181526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasting-induced changes in the hypothalamic-pituitary-GH axis in the absence of GH expression: lessons from the spontaneous dwarf rat.
    Park S; Sohn S; Kineman RD
    J Endocrinol; 2004 Mar; 180(3):369-78. PubMed ID: 15012591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Complex World of Regulation of Pituitary Growth Hormone Secretion: The Role of Ghrelin, Klotho, and Nesfatins in It.
    Devesa J
    Front Endocrinol (Lausanne); 2021; 12():636403. PubMed ID: 33776931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that ghrelin is as potent as growth hormone (GH)-releasing hormone (GHRH) in releasing GH from primary pituitary cell cultures of a nonhuman primate (Papio anubis), acting through intracellular signaling pathways distinct from GHRH.
    Kineman RD; Luque RM
    Endocrinology; 2007 Sep; 148(9):4440-9. PubMed ID: 17540720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homologous and heterologous in vitro regulation of pituitary receptors for somatostatin, growth hormone (GH)-releasing hormone, and ghrelin in a nonhuman primate (Papio anubis).
    Córdoba-Chacón J; Gahete MD; Castaño JP; Kineman RD; Luque RM
    Endocrinology; 2012 Jan; 153(1):264-72. PubMed ID: 22109886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone-releasing hormone receptor (GHRH-R) and growth hormone secretagogue receptor (GHS-R) mRNA levels during postnatal development in male and female rats.
    Kamegai J; Wakabayashi I; Kineman RD; Frohman LA
    J Neuroendocrinol; 1999 Apr; 11(4):299-306. PubMed ID: 10223284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothalamic/pituitary-axis of the spontaneous dwarf rat: autofeedback regulation of growth hormone (GH) includes suppression of GH releasing-hormone receptor messenger ribonucleic acid.
    Kamegai J; Unterman TG; Frohman LA; Kineman RD
    Endocrinology; 1998 Aug; 139(8):3554-60. PubMed ID: 9681507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oestrogen replacement in vivo rescues the dysfunction of pituitary somatotropes in ovariectomised aromatase knockout mice.
    Yan M; Jones ME; Hernandez M; Liu D; Simpson ER; Chen C
    Neuroendocrinology; 2005; 81(3):158-66. PubMed ID: 16015026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.